NCT07506135

Brief Summary

The goal of this randomized placebo-controlled split-mouth clinical trial is to determine whether aromatherapy using lemongrass essential oil can reduce pain, dental anxiety, and physiological stress responses during orthodontic extraction of maxillary premolars . The main questions it aims to answer are:

  • Does aromatherapy reduce pain perception during and after tooth extraction as measured by the Visual Analog Scale (VAS)?
  • Does aromatherapy reduce dental anxiety and improve oral health-related quality of life during the extraction procedure as measured by the Modified Dental Anxiety Scale (MDAS-DEP) and Oral Health Impact Profile-14 (OHIP-14)?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 20, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 7, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 7, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 8, 2026

Completed
24 days until next milestone

First Posted

Study publicly available on registry

April 1, 2026

Completed
Last Updated

April 1, 2026

Status Verified

March 1, 2026

Enrollment Period

2 months

First QC Date

March 8, 2026

Last Update Submit

March 27, 2026

Conditions

Keywords

AromatherapyLemongrass essential oilOrthodontic extractionMaxillary premolarDental anxietySplit-mouth trial

Outcome Measures

Primary Outcomes (3)

  • Pain perception during and after tooth extraction

    Measure: Pain intensity assessed using a Visual Analog Scale (VAS), a 10-centimeter scale ranging from 0 to 10, where: 0 = No pain 10 = Worst imaginable pain Higher scores indicate greater pain intensity (worse outcome).

    Peri-procedural (during local anesthesia administration and forceps application), and at 2 hours, 12 hours, 24 hours, and 48 hours post-procedure

  • Dental anxiety during extraction procedure

    Measure: Anxiety assessed using the Modified Dental Anxiety Scale for Dental Extraction Procedure (MDAS-DEP). The scale consists of 5 items with total scores ranging from 5 to 25, where: 5 = No anxiety 25 = Extreme anxiety Higher scores indicate greater anxiety levels (worse outcome).

    Baseline (pre-procedure) and immediately post-procedure (within 30 minutes after extraction)

  • Oral health-related quality of life following extraction

    Measure: Oral health-related quality of life assessed using the Oral Health Impact Profile-14 (OHIP-14) questionnaire. Scores range from 0 to 56, where: 0 = No impact (best quality of life) 56 = Maximum negative impact (worst quality of life) Higher scores indicate poorer oral health-related quality of life (worse outcome).

    24 hours post-procedure

Secondary Outcomes (5)

  • Systolic Blood Pressure

    Baseline (pre-procedure), intra-procedural (during local anesthesia administration), and immediately post-procedure (within 30 minutes after extraction)

  • Diastolic Blood Pressure

    Baseline (pre-procedure), intra-procedural, and immediately post-procedure (within 30 minutes after extraction)

  • Heart Rate

    Baseline (pre-procedure), intra-procedural, and immediately post-procedure (within 30 minutes after extraction)

  • Respiratory Rate

    Baseline (pre-procedure), intra-procedural, and immediately post-procedure (within 30 minutes after extraction)

  • Oxygen Saturation

    Baseline (pre-procedure), intra-procedural, and immediately post-procedure (within 30 minutes after extraction)

Study Arms (2)

Aromatherapy (Lemongrass Essential Oil)

EXPERIMENTAL

Participants receive aromatherapy using lemongrass essential oil delivered through an electric diffuser during the orthodontic extraction procedure. Two drops of lemongrass essential oil are diluted in 100 mL of water and diffused in the operatory environment starting approximately 30 minutes before the extraction procedure and continued throughout the procedure. In the split-mouth study design, this intervention is applied during one of the extraction sessions.

Other: Lemongrass Aromatherapy

Placebo Aromatherapy (Distilled Water Diffusion)

PLACEBO COMPARATOR

Participants receive placebo aromatherapy using distilled water diffusion during the orthodontic extraction procedure. Distilled water is placed in the same electric diffuser under identical environmental conditions starting 30 minutes before the extraction procedure and continued throughout the procedure. This serves as the control condition in the split-mouth design.

Other: Placebo Aromatherapy

Interventions

Lemongrass essential oil diluted in water and administered using an electric diffuser in the dental operatory to provide inhalational aromatherapy during the extraction procedure.

Aromatherapy (Lemongrass Essential Oil)

Distilled water administered using an electric diffuser in the dental operatory to mimic aromatherapy exposure without active essential oil.

Placebo Aromatherapy (Distilled Water Diffusion)

Eligibility Criteria

Age12 Years - 25 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patients indicated for bilateral orthodontic extraction of maxillary first or second premolars
  • Age 12 to 25 years
  • Willing to provide informed consent/assent as applicable

You may not qualify if:

  • Use of medication within 15 days before the study
  • Hypersensitivity to drugs, substances, or materials used in the trial
  • Smokers
  • Pregnancy or lactation
  • Inability to complete the questionnaire
  • Preoperative inflammatory or infectious condition

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

PGIDS, Rohtak

Rohtak, Haryana, 124001, India

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Dr Virendra Singh, MDS

    Postgraduate Institute of Dental Sciences Rohtak

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 8, 2026

First Posted

April 1, 2026

Study Start

November 20, 2025

Primary Completion

January 7, 2026

Study Completion

January 7, 2026

Last Updated

April 1, 2026

Record last verified: 2026-03

Locations